Envision Healthcare Holdings Inc. (NYSE:EVHC) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, October 20th. Analysts expect Envision Healthcare Holdings to post earnings of $0.37 per share for the quarter. Envision Healthcare Holdings has set its FY16 guidance at $1.42-1.47 EPS.

Envision Healthcare Holdings (NYSE:EVHC) last announced its quarterly earnings results on Wednesday, August 3rd. The company reported $0.34 EPS for the quarter, missing the Zacks’ consensus estimate of $0.36 by $0.02. Envision Healthcare Holdings had a net margin of 1.88% and a return on equity of 11.74%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.66 billion. During the same period in the previous year, the business posted $0.37 earnings per share. The business’s revenue for the quarter was up 21.2% compared to the same quarter last year. On average, analysts expect Envision Healthcare Holdings to post $1.43 EPS for the current fiscal year and $1.67 EPS for the next fiscal year.

Earnings History for Envision Healthcare Holdings (NYSE:EVHC)

Shares of Envision Healthcare Holdings Inc. (NYSE:EVHC) opened at 21.83 on Wednesday. The stock’s 50 day moving average price is $21.84 and its 200-day moving average price is $23.26. Envision Healthcare Holdings Inc. has a 52 week low of $18.31 and a 52 week high of $37.42. The firm has a market capitalization of $4.09 billion, a price-to-earnings ratio of 36.38 and a beta of 0.42.

Several equities analysts have recently commented on EVHC shares. Mizuho increased their price objective on Envision Healthcare Holdings from $24.00 to $27.00 and gave the company a “neutral” rating in a research report on Friday, June 24th. Zacks Investment Research lowered Envision Healthcare Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, July 5th. Jefferies Group reiterated a “buy” rating on shares of Envision Healthcare Holdings in a research report on Monday, July 11th. Canaccord Genuity reiterated a “buy” rating and set a $32.00 price objective on shares of Envision Healthcare Holdings in a research report on Friday, August 5th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $31.00 price objective on shares of Envision Healthcare Holdings in a research report on Thursday, September 8th. Seven equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Envision Healthcare Holdings presently has a consensus rating of “Buy” and an average price target of $30.85.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. FMR LLC boosted its position in Envision Healthcare Holdings by 36.7% in the second quarter. FMR LLC now owns 8,128,989 shares of the company’s stock worth $206,232,000 after buying an additional 2,180,342 shares during the last quarter. Sachem Head Capital Management LP purchased a new position in Envision Healthcare Holdings during the second quarter worth approximately $124,947,000. BlackRock Institutional Trust Company N.A. boosted its position in Envision Healthcare Holdings by 1.0% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 4,867,416 shares of the company’s stock worth $123,486,000 after buying an additional 50,116 shares during the last quarter. Janus Capital Management LLC boosted its position in Envision Healthcare Holdings by 183.3% in the second quarter. Janus Capital Management LLC now owns 3,657,238 shares of the company’s stock worth $92,781,000 after buying an additional 2,366,235 shares during the last quarter. Finally, BlackRock Fund Advisors boosted its position in Envision Healthcare Holdings by 3.6% in the second quarter. BlackRock Fund Advisors now owns 2,334,850 shares of the company’s stock worth $59,235,000 after buying an additional 82,155 shares during the last quarter.

About Envision Healthcare Holdings

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

5 Day Chart for NYSE:EVHC

Receive News & Stock Ratings for Envision Healthcare Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Holdings Inc. and related stocks with our FREE daily email newsletter.